Robert A. O'Reilly, Paul M. Aggeler, Lois S. Leong
Year: | 2024 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | 2005 | 2004 | 2002 | 2001 | 1998 | 1997 | 1996 | 1994 | 1993 | 1992 | 1991 | 1989 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | 1978 | 1977 | 1976 | 1975 | 1974 | 1973 | 1972 | 1971 | 1970 | 1969 | 1968 | 1967 | 1966 | 1965 | 1964 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 1 | 3 | 4 | 1 | 9 | 1 | 1 | 4 | 3 | 3 | 5 | 4 | 2 | 2 | 2 | 6 | 1 | 1 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 1 | 2 | 5 | 5 | 2 | 4 | 3 | 3 | 1 | 2 | 3 | 7 | 4 | 6 | 6 | 4 | 4 | 2 | 3 | 4 | 6 | 4 | 3 | 1 | 2 | 153 |
Title and authors | Publication | Year |
---|---|---|
A fully automatic tool for development of population pharmacokinetic models
Chen X, Nordgren R, Belin S, Hamdan A, Wang S, Yang T, Huang Z, Carter SJ, Buatois S, Abrantes JA, Hooker AC, Karlsson MO |
CPT: Pharmacometrics & Systems Pharmacology | 2024 |
Antithrombotic and Antiplatelet Drug Toxicity
DB Liss, ME Mullins |
Critical Care Clinics | 2021 |
A Primary Amide-Functionalized Heterogeneous Catalyst for the Synthesis of Coumarin-3-carboxylic Acids via a Tandem Reaction
D Markad, S Khullar, SK Mandal |
Inorganic Chemistry | 2020 |
Environmental Toxicants: Human Exposures and Their Health Effects
M Lippmann, GD Leikauf |
2020 | |
In silico, 6LU7 protein inhibition using dihydroxy-3-phenyl coumarin derivatives for SARS-CoV-2
M ÖZDEMİR, B KÖKSOY, D CEYHAN, M BULUT, B YALCİN |
2020 | |
Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
I Rubinstein, R van Breemen, DG Nosal, G Weinberg, RC Hershow, DL Feinstein |
Drugs in R & D | 2019 |
Photoinduced cyclization of alkynoates to coumarins with N-Iodosuccinimide as a free-radical initiator under ambient and metal-free conditions
Z Wang, X Li, L Wang, P Li |
Tetrahedron | 2019 |
Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand
S Hennig, JA Hannam, CM Kirkpatrick, CE Staatz, S Holford, SB Duffull, HS AlSallami, BG Charles, N Holford, DJ Foster |
CPT Pharmacometrics Syst. Pharmacol. | 2019 |
Study on Anti-Tumor Activity of Novel 3-Substituted 4 Anilino-Coumarin Derivatives Using Quantitative Structure-Activity Relationship (QSAR)
DE Putri, HD Pranowo, W Haryadi |
Materials Science Forum | 2019 |
Pd-catalysed carbonylative annulation of salicylaldehydes with benzyl chlorides using N -formylsaccharin as a CO surrogate
VK Yadav, VP Srivastava, LD Yadav |
New Journal of Chemistry | 2018 |
No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with Dulaglutide
A la Peña, X Cui, J Geiser, C Loghin |
Clinical Pharmacokinetics | 2017 |
PharmML in Action: an Interoperable Language for Modeling and Simulation: PharmML in Action
R Bizzotto, E Comets, G Smith, F Yvon, NR Kristensen, MJ Swat |
CPT Pharmacometrics Syst. Pharmacol. | 2017 |
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics: Evaluation Graphs for Population PK/PD Models
TH Nguyen, MS Mouksassi, N Holford, N Al-Huniti, I Freedman, AC Hooker, J John, MO Karlsson, DR Mould, JJ Ruixo, EL Plan, R Savic, JG van Hasselt, B Weber, C Zhou, E Comets, F Mentré |
CPT Pharmacometrics Syst. Pharmacol. | 2017 |
Assessing robustness of designs for random effects parameters for nonlinear mixed-effects models
SB Duffull, AC Hooker |
Journal of Pharmacokinetics and Pharmacodynamics | 2017 |
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins
QX Ooi, DF Wright, RC Tait, GK Isbister, SB Duffull |
Clinical Pharmacokinetics | 2017 |
Anticoagulant Rodenticides and Wildlife
NW van Brink, JE Elliott, RF Shore, BA Rattner |
2017 | |
The Long-Lasting Rodenticide Brodifacoum Induces Neuropathology in Adult Male Rats
S Kalinin, N Marangoni, K Kowal, A Dey, K Lis, S Brodsky, R van Breemen, Z Hauck, R Ripper, I Rubinstein, G Weinberg, DL Feinstein |
Toxicological Sciences | 2017 |
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins
, DF Wright, RC Tait, GK Isbister, SB Duffull |
Clinical Pharmacokinetics | 2017 |
No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with Dulaglutide
A de la Peña, X Cui, J Geiser, C Loghin |
Clinical Pharmacokinetics | 2017 |
The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures: The emerging threat of superwarfarins
DL Feinstein, BS Akpa, MA Ayee, AI Boullerne, D Braun, SV Brodsky, D Gidalevitz, Z Hauck, S Kalinin, K Kowal, I Kuzmenko, K Lis, N Marangoni, MW Martynowycz, I Rubinstein, R Breemen, K Ware, G Weinberg |
Annals of the New York Academy of Sciences | 2016 |
Electroreductive Dimerization of Coumarin and Coumarin Analogues at Carbon Cathodes
EM Pasciak, JT Rittichier, CH Chen, MS Mubarak, MS VanNieuwenhze, DG Peters |
The Journal of Organic Chemistry | 2015 |
Toxin-induced Coagulopathy
P Chai, K Babu |
Emergency Medicine Clinics of North America | 2014 |
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies: Software for designs in pharmacometrics
J Nyberg, C Bazzoli, K Ogungbenro, A Aliev, S Leonov, S Duffull, AC Hooker, F Mentré |
British Journal of Clinical Pharmacology | 2014 |
Is personalized medicine a dream or a reality?
BL Morse, RB Kim |
Critical Reviews in Clinical Laboratory Sciences | 2014 |
Reduction of Substituted Phenyl 2-Chloroacetates at Silver Cathodes: Electrosynthesis of Coumarins
EM Pasciak, DG Peters |
Journal of The Electrochemical Society | 2014 |
How Warfarin’s Structural Diversity Influences Its Phospholipid Bilayer Membrane Permeation
BC Karlsson, GD Olsson, R Friedman, AM Rosengren, H Henschel, IA Nicholls |
The Journal of Physical Chemistry B | 2013 |
Study of structure–activity relationship of enantiomeric, protonated and deprotonated forms of warfarin via vibrational spectroscopy and DFT calculations
A Mishra, SK Srivastava, D Swati |
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy | 2013 |
The MAK-Collection for Occupational Health and Safety: Annual Thresholds and Classifications for the Workplace
M Nasterlack |
The MAK-Collection for Occupational Health and Safety: Annual Thresholds and Classifications for the Workplace | 2013 |
Biotransformation (Metabolism) of Pesticides
E Hodgson |
Pesticide Biotransformation and Disposition | 2012 |
Synthesis of Coumarins via Pd-Catalyzed Oxidative Cyclocarbonylation of 2-Vinylphenols
J Ferguson, F Zeng, H Alper |
Organic letters | 2012 |
Standardized Visual Predictive Check Versus Visual Predictive Check for Model Evaluation
DD Wang, S Zhang |
The Journal of Clinical Pharmacology | 2012 |
Development of a Bayesian Forecasting Method for Warfarin Dose Individualisation
DF Wright, SB Duffull |
Pharmaceutical Research | 2011 |
Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure
A Lee, M Crowther |
Journal of Thrombosis and Thrombolysis | 2011 |
Understanding the time course of pharmacological effect: a PKPD approach
DF Wright, HR Winter, SB Duffull |
British Journal of Clinical Pharmacology | 2011 |
NovelCYP2C9andVKORC1gene variants associated with warfarin dosage variability in the South African black population
C Mitchell, N Gregersen, A Krause |
Pharmacogenomics | 2011 |
Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation
IY Gong, UI Schwarz, N Crown, GK Dresser, A Lazo-Langner, GY Zou, DM Roden, CM Stein, M Rodger, PS Wells, RB Kim, RG Tirona, UM Zanger |
PloS one | 2011 |
Implementation and Evaluation of the SAEM Algorithm for Longitudinal Ordered Categorical Data with an Illustration in Pharmacokinetics–Pharmacodynamics
RM Savic, F Mentré, M Lavielle |
The AAPS Journal | 2010 |
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0
C Bazzoli, S Retout, F Mentré |
Computer Methods and Programs in Biomedicine | 2010 |
Hayes' Handbook of Pesticide Toxicology
M Lotti |
Hayes' Handbook of Pesticide Toxicology | 2010 |
Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report
G Giunta |
Case Reports in Medicine | 2010 |
Effect of gefitinib on warfarin antithrombotic activity
S Arai, H Mitsufuji, Y Nishii, S Onoda, S Ryuge, M Wada, K Katono, M Iwasaki, A Takakura, S Otani, M Yamamoto, T Yanaihara, M Yokoba, M Kubota, M Katagiri, T Fukui, H Kobayashi, N Yanase, R Hataishi, N Masuda |
International Journal of Clinical Oncology | 2009 |
Malabsorption-associated warfarin resistance
BJ Sabol, RR Basa, CE Wilkins |
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2009 |
Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium
S Ghosh, UR Pendurthi, A Steinoe, CT Esmon, LV Rao |
The Journal of biological chemistry | 2007 |
Glucuronidation of Monohydroxylated Warfarin Metabolites by Human Liver Microsomes and Human Recombinant UDP-Glucuronosyltransferases
A Zielinska, CF Lichti, S Bratton, NC Mitchell, A Gallus-Zawada, , M Finel, GP Miller, A Radominska-Pandya, JH Moran |
The Journal of pharmacology and experimental therapeutics | 2007 |
Pharmacodynamic Model for Warfarin under Thrombo-test Monitoring
S Sato, F Hongo, N Hanawa, M Hirokami, K Matsuda, Y Minemawari, M Takigahira, T Toda, N Kurosawa, E Owada |
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) | 2006 |
Compliance-Guided Therapy: A New Insight Into the Potential Role of Clinical Pharmacologists
A Blesius, S Chabaud, M Cucherat, P Mismetti, JP Boissel, P Nony |
Clinical Pharmacokinetics | 2006 |
Factor VIIa binding and internalization in hepatocytes
G Hjortoe, BB Sorensen, LC Petersen, LV Rao |
Journal of Thrombosis and Haemostasis | 2005 |
Anticoagulant Rodenticides
BE Watt, AT Proudfoot, SM Bradberry, JA Vale |
Toxicological Reviews | 2005 |
Comparative Pharmacokinetics of Vitamin K Antagonists
M Ufer |
Clinical Pharmacokinetics | 2005 |
Rodenticides
L Gamelin, P Harry |
EMC - Toxicologie-Pathologie | 2005 |
Significant Effect of Capecitabine on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Cancer
R Camidge, B Reigner, J Cassidy, S Grange, M Abt, E Weidekamm, D Jodrell |
Journal of Clinical Oncology | 2005 |
Comparative Pharmacokinetics of Vitamin K Antagonists: Warfarin, Phenprocoumon and Acenocoumarol
M Ufer |
Clinical Pharmacokinetics | 2005 |
Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism
M McGuire, PP Dobesh |
Journal of Pharmacy Practice | 2004 |
Assessment of risks of brodifacoum to non-target birds and mammals in New Zealand
Charles T Eason, Elaine C Murphy, Geoffrey R G Wright, Eric B Spurr |
Ecotoxicology | 2002 |
Handbook of Pesticide Toxicology
RM Hollingworth |
Handbook of Pesticide Toxicology | 2001 |
Antithrombotic Therapy for Venous Thromboembolic Disease
TM Hyers, G Agnelli, RD Hull, TA Morris, M Samama, V Tapson, JG Weg |
Chest | 2001 |
Oral Anticoagulants
J Hirsh, JE Dalen, DR Anderson, L Poller, H Bussey, J Ansell, D Deykin, JT Brandt |
Chest | 1998 |
Determination of kinetic parameters for prothrombin complex activity during initiation of anticoagulation
M Kuranari, M Hara, T Saikawa, Y Kodama, H Matsuo, T Sakata, M Takeyama |
Journal of Clinical Pharmacy and Therapeutics | 1997 |
Warfarin Withdrawal: Pharmacokinetic-Pharmacodynamic Considerations
G Palareti, C Legnani |
Clinical Pharmacokinetics | 1996 |
Capillary electrophoretic separation of anticoagulant rodenticides in aqueous electrolytes modified with organic solvents
C Stathakis, PL Warburton, RM Cassidy |
Journal of Chromatography A | 1994 |
Hagers Handbuch der Pharmazeutischen Praxis
M Albinus, G Amschler, U Amschler, E von Angerer, W Barthel, A Bauer, K Bauer, J Beckmann, W Beil, J Beitz, P Berscht, T Beyrich, K Binder, R Böhme, HH Borchert, F Bracher, H Bräunlich, K Brinkmann, F von Bruchhausen, K Brune, A Büge, W Christ, M Cimbollek, R Daniels, G Dannhardt, HJ Duchstein, S Ebel, K Eger, P Emig, T Erker, MS Fernandez-Alfonso, AW Frahm, M Frahm, KJ Freundt, D Geffken, U Geis, E Glusa, B Göber, J Gödicke, M Goppelt-Strübe, W Gössling, A Graul, S Greiner, A Grisk, M Grosam, M von Gruchalla, M Gütschow, A Haberkorn, E Hackenthal, A Häfner, B Haluszczynski, A Harder, S Hartmann, S Hartmann, D Heber, G Heinemeyer, A Hensel, S Hoedt-Schmidt, H Hoffmann, U Hoffmann-Schollmayer, U Holzgrabe, M Hug, W Ibrom, E Inkmann, J Jürgens, B Kaiser, DA Kalbhen, N Khudeir, W Kiefer, D Kleinsorge, C Klett, S Klett, M Klingmüller, HP Klöcking, G Kobal, A Kramer, M Kreher, G Kreutz, R Kroker, D Landsiedel-Maier, J Lehmann, MS Lehner, S Leiner, H Löwe, J Mann, D Manns, W Matthiessen, A Maurer, W Meindl, K Menges, P Messinger, HJ Mest, FP Meyer, J Mollière, R Morgenstern, W Morick, J Mössner, C Müller, D Müller, K Müller, W Müller, A Mülsch, T Netzer, M Neugebauer, U Niemeyer, P Nuhn, B Nürnberg, J Oertel, M Oettel, H Oßwald, R Ott, T Ott, T Otzen, P Pachaly, H Pelzer, KU Petersen, M Pickert, A Pies, K Pietrzik, D Preiss, H Priewer, O Queckenberg, E Reimann, J Remien, R Rettig, A Reymann, J Richter, H Rommelspacher, U Rose, G Rücker, K Schaefer, H Schlager, W Schleicher, H Schleinitz, W Schlichter, H Schmidhammer, G Schmidt, T Schmidt, J Schräder, T Schulz, G Schulze, P Schwanz, H Schwilden, M Serke, G Skopp, M Spohn, R Stahlmann, JP Stasch, C Steffen, J Steinmeyer, KH Surborg, U Sürig, I Szelenyi, R Troschütz, M Verborg, EJ Verspohl, FJ Volk, H Walther, H Weber, J Wede, M Wenzel, M Weyandt-Spangenberg, S Wich, H Winterhoff, R Wintersteiger, F Woltmann, D Youssef, A Ziegler |
1994 | |
Clinically Significant Drug Interactions with the Oral Anticoagulants:
MD Freedman, AG Olatidoye |
Drug Safety | 1994 |
Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
A Yacobi, JP Skelly, VP Shah, LZ Benet |
1993 | |
Oral Anticoagulants: Pharmacodynamics, Clinical Indications and Adverse Effects
MD Freedman |
The Journal of Clinical Pharmacology | 1992 |
Classes of Pesticides
AF Pelfrene |
Classes of Pesticides | 1991 |
Decreased Hypoprothrombinemic Response to Warfarin Secondary to the Warfarin-Nafcillin Interaction
VA Shovick, TL Rihn |
1991 | |
Clinical Pharmacokinetic Considerations in the Control of Oral Anticoagulant Therapy:
HG Shetty, AG Fennerty, PA Routledge |
Clinical Pharmacokinetics | 1989 |
The anticoagulant activity of some selected warfarin analogues
AO Obaseki, HB Coker |
Journal of Pharmacy and Pharmacology | 1987 |
ASPECTS OF ANTICOAGULANT ACTION: A Review of the Pharmacology, Metabolism and Toxicology of Warfarin and Congeners
FA Sutcliff, AD MacNicoll, GG Gibson |
Drug Metabolism and Drug Interactions | 1987 |
Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins
BK Park, IA Choonara, BP Haynes, AM Breckenridge, RG Malia, FE Preston |
British Journal of Clinical Pharmacology | 1986 |
The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer
PE Lnning, PM Ueland, S Kvinnsland |
Cancer Chemotherapy and Pharmacology | 1986 |
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
E Jucker |
1986 | |
Reversed-phase high-performance liquid chromatographic method for the determination of warfarin from biological fluids in the low nanogram range
JM Steyn, HM Merwe, MJ Kock |
Journal of Chromatography B: Biomedical Sciences and Applications | 1986 |
Clinical Pharmacokinetics and Pharmacodynamics of Warfarin: Understanding the Dose-Effect Relationship
NH Holford |
Clinical Pharmacokinetics | 1986 |
A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit
AM Breckenridge, S Cholerton, JA Hart, BK Park, AK Scott |
British Journal of Pharmacology | 1985 |
Progress in Medicinal Chemistry
JR Brown, SH Imam |
Progress in Medicinal Chemistry | 1985 |
High-performance liquid chromatographic strategies for the determination and confirmation of anticoagulant rodenticide in animal tissues
K Hunter |
Journal of Chromatography A | 1985 |
Drugs in the Management of Heart Disease
A Breckenridge |
1985 | |
Uses of heparin and warfarin
JV Lloyd |
The Medical Journal of Australia | 1985 |
Coagulation recovery after warfarin-induced hypoprothrombinaemia by oral administration of liposomally-associated vitamin K1 to rabbits
M Nagata, T Yotsuyanagi, M Nonomura, K Ikeda |
Journal of Pharmacy and Pharmacology | 1984 |
Antithrombotic Therapy for Venous Thromboembolism
TM Hyers |
Clinics in Chest Medicine | 1984 |
Acenocoumarol and its amino and acetamido metabolites. Comparative pharmacokinetics and pharmacodynamics in the rat
HH Thijssen, LG Baars, MJ Reijnders |
Journal of Pharmacy and Pharmacology | 1983 |
Warfarin: a review with emphasis on its use in the horse
A Vrins, G Carlson, B Feldman |
The Canadian veterinary journal. La revue vétérinaire canadienne | 1983 |
Dose-Dependent Pharmacokinetics: Emphasis on Phase I Metabolism
PG Dayton, JE Sanders |
Drug Metabolism Reviews | 1983 |
Drug Interactions with Warfarin:
MJ Serlin, AM Breckenridge |
Drugs | 1983 |
Fixation plasmatique et pharmacocinétique des médicaments
JP Tillement, R Zini, S Glasson, B Jacotot |
La Revue de Médecine Interne | 1982 |
Inhibition by coumadin anticoagulants of enzymatic outer ring monodeiodination of iodothyronines
A Goswami, JL Leonard, IN Rosenberg |
Biochemical and Biophysical Research Communications | 1982 |
Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man
RA O'Reilly |
Circulation | 1982 |
Pharmacokinetics of warfarin in rabbits during short-term and long-term uraemia
E Tvedegaard, J Ladefoged, O Ladefoged |
Journal of Veterinary Pharmacology and Therapeutics | 1981 |
Laser-induced photoacoustic detector for high-performance liquid chromatography
S Oda, T Sawada |
Analytical Chemistry | 1981 |
High-performance liquid chromatography separation and fluorescence detection of warfarin and its metabolites by postcolumn acid/base manipulation
SH Lee, LR Field, WN Howald, WF Trager |
Analytical Chemistry | 1981 |
Influence of dietary protein on the response of rats receiving toxic levels of warfarin
DL Barber, HW Colvin |
Toxicology and Applied Pharmacology | 1980 |
A preliminary report on the use of Warfarin in the Treatment of Navicular Disease
CM Colles |
Equine Veterinary Journal | 1979 |
Clinical Pharmacokinetics of Oral Anticoagulants:
JG Kelly, K OʼMalley |
Clinical Pharmacokinetics | 1979 |
Treatment and protherombin responses during warfarin toxicosis in rats and mice
L Penumarthy, FW Oehme |
Toxicology | 1978 |
Comparison of high-performance liquid chromatography and a spectrophotometric technique for determining plasma warfarin
WB Forman, J Shlaes |
Journal of Chromatography B: Biomedical Sciences and Applications | 1978 |
The Effect of Furosemide and Bumetanide on Warfarin Metabolism and Anticoagulant Response
CM Nilsson, ES Horton, DS Robinson |
The Journal of Clinical Pharmacology | 1978 |
Drug administration in renal failure
JS Cheigh |
The American Journal of Medicine | 1977 |
Warfarin Elimination and Responsiveness in Patients with Renal Dysfunction
K Bachmann, R Shapiro, J Mackiewicz |
The Journal of Clinical Pharmacology | 1977 |
Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma
OG Nilsen, L Storstein, S Jacobsen |
Biochemical Pharmacology | 1977 |
Distribution pharmacokinetics of warfarin in the rat, a non-linear multicompartment model
M Kekki, RJ Julkunen, B Wahlstrm |
Naunyn-Schmiedeberg's Archives of Pharmacology | 1977 |
Interindividual Differences in the Response to Oral Anticoagulants:
AM Breckenridge |
Drugs | 1977 |
Plasma Protein Binding of Phenytoin and Warfarin in Patients Undergoing Renal Transplantation1:
I Odar-Cederlof |
Clinical Pharmacokinetics | 1977 |
Protein Binding of Coumarin Anticoagulants in Disease States:
K Bachmann, R Shapiro |
Clinical Pharmacokinetics | 1977 |
GLC determination of plasma concentrations of phenprocoumon
KK Midha, JW Hubbard, JK Cooper, IJ McGilveray |
Journal of Pharmaceutical Sciences | 1976 |
Multimodal distribution of warfarin binding to protein in serum of male-sprague dawley rats
JT Slattery, A Yacobi, G Levy |
Life Sciences | 1976 |
The Stereoselective Interaction of Warfarin and Metronidazole in Man
RA O'Reilly |
New England Journal of Medicine | 1976 |
Pharmacodynamic and Pharmacokinetic Drug Interactions with Coumarin Anticoagulants:
SM MacLeod, EM Sellers |
Drugs | 1976 |
Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references
LA Pagliaro, LZ Benet |
Journal of Pharmacokinetics and Biopharmaceutics | 1975 |
Comparative pharmacokinetics of coumarin anticoagulants XIV: Relationship between protein binding, distribution, and elimination kinetics of warfarin in rats
A Yacobi, G Levy |
Journal of Pharmaceutical Sciences | 1975 |
Continued anticoagulation in oral surgery procedures
SM Roser, B Rosenbloom |
Oral Surgery, Oral Medicine, Oral Pathology | 1975 |
Drug Design
HJ Herms, V Taenzer |
Drug Design | 1975 |
Anticoagulant effect and plasma kinetics of fluorophenindione after a single dose in man
, JJ Thbault, C Mattei, P d'Athis, C Blatrix |
European Journal of Clinical Pharmacology | 1975 |
A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man
G Houin, JJ Thbault, P d'Athis, , |
European Journal of Clinical Pharmacology | 1975 |
Toxic effects of warfarin in rats fed different diets
HW Colvin, WL Wang |
Toxicology and Applied Pharmacology | 1974 |
Comparative pharmacokinetics of coumarin anticoagulants X: Relationship between distribution, elimination, and anticoagulant action of warfarin
A Yacobi, LB Wingard, G Levy |
Journal of Pharmaceutical Sciences | 1974 |
Effect of plasma protein binding on elimination of warfarin
G Levy, A Yacobi |
Journal of Pharmaceutical Sciences | 1974 |
GLC determination of warfarin in human plasma
DG Kaiser, RS Martin |
Journal of Pharmaceutical Sciences | 1974 |
GLC determination of plasma levels of warfarin
KK Midha, IJ McGilveray, JK Cooper |
Journal of Pharmaceutical Sciences | 1974 |
Blood
WH Crosby |
Blood | 1974 |
Multiple-dose kinetics of oral anticoagulants: Methods of analysis and optimized dosing
TG Theofanous, RG Barile |
Journal of Pharmaceutical Sciences | 1973 |
Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man*
DS Hewick, J Mcewen |
Journal of Pharmacy and Pharmacology | 1973 |
Neunundsiebzigster Kongress
K Miehlke |
1973 | |
Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man
C Harvengt, JP Desager |
European Journal of Clinical Pharmacology | 1973 |
Multiple-dose kinetics of pharmacological effects of indirect anticoagulants
TG Theofanous, VF Smolen |
Journal of Pharmaceutical Sciences | 1972 |
Vitamin K and warfarin
IL Woolf, BM Babior |
The American Journal of Medicine | 1972 |
Drugs Affecting Therapy with Anticoagulants
J Eipe |
Medical Clinics of North America | 1972 |
Effect of cholestyramine on the gastrointestinal absorption of phenprocoumon and acetylosalicylic acid in man
, W Eiden, M Schettle, M Hahn, E Walter, E Weber |
European Journal of Clinical Pharmacology | 1972 |
In vivo andin vitro availability of commercial warfarin tablets
JG Wagner, PG Welling, KP Lee, JE Walker |
Journal of Pharmaceutical Sciences | 1971 |
Drug Interactions with Coumarin Anticoagulants
J Koch-Weser, EM Sellers |
New England Journal of Medicine | 1971 |
Comparison of plasma concentrations of warfarin measured by both simple extraction and TLC methods
PG Welling, KP Lee, U Khanna, JG Wagner |
Journal of Pharmaceutical Sciences | 1970 |
The Second Reported Kindred with Hereditary Resistance to Oral Anticoagulant Drugs
RA O'Reilly |
New England Journal of Medicine | 1970 |
Warfarin Therapy
D Deykin |
New England Journal of Medicine | 1970 |
Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin
RA O'Reilly |
Journal of Clinical Investigation | 1969 |
Comparative pharmacokinetics of coumarin anticoagulants V: Kinetics of warfarin elimination in the rat, dog, and rhesus monkey compared to man
R Nagashima, G Levy |
Journal of Pharmaceutical Sciences | 1969 |
Essays in Toxicology
RP Smith |
Essays in Toxicology | 1969 |
Studies on Coumarin Anticoagulant Drugs
RA O'Reilly, JI Ohms, CH Motley |
The Journal of biological chemistry | 1969 |
VARIATIONS IN METABOLISM OF COUMARIN ANTICOAGULANT DRUGS
HM Solomon |
Annals of the New York Academy of Sciences | 1968 |
HEREDITARY RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS IN MAN AND RAT
RA O'Reilly, JG Pool, PM Aggeler† |
Annals of the New York Academy of Sciences | 1968 |
Comparative pharmacokinetics of coumarin anticoagulants I. Unusual interaction of bishydroxycoumarin with plasma proteins—development of a new assay
R Nagashima, G Levy, E Nelson |
Journal of Pharmaceutical Sciences | 1968 |
COUMARIN ANTICOAGULANT REQUIREMENT IN RELATION TO SERUM CHOLESTEROL AND TRIGLYCERIDE LEVEL
K Pyörälä, EA Nikkilä, P Vuopio, G Myllylä |
Acta Medica Scandinavica | 1968 |
Stabilization of Anticoagulant Therapy By Simultaneous Coumarin and Vitamin k aDministration
JA Udall |
Angiology | 1968 |
Studies on Coumarin Anticoagulant Drugs: Initiation of Warfarin Therapy Without a Loading Dose
RA O'reilly, PM Aggeler |
Circulation | 1968 |
Studies on the Coumarin Anticoagulant Drugs: Interaction of Human Plasma Albumin and Warfarin Sodium RA O'Reilly |
Journal of Clinical Investigation | 1967 |
Safe per-operative anticoagulation
J Wieberdink |
Thorax | 1967 |
Warfarin resistance
RJ Lewis, M Spivack, TH Spaet |
The American Journal of Medicine | 1967 |
Potentiation of Anticoagulant Effect of Warfarin by Phenylbutazone
PM Aggeler, RA O'Reilly, L Leong, PE Kowitz |
New England Journal of Medicine | 1967 |
Physicochemical and physiologic factors affecting the absorption of warfarin in man
RA O'reilly, E Nelson, G Levy |
Journal of Pharmaceutical Sciences | 1966 |
Anticoagulant Therapy in Coronary Artery Disease
S Wessler, LW Gaston |
Circulation | 1966 |
The Effect of Dicumarol, Diphacinone and Pivalyl Upon Blood Prothrombin Time of Chicks
OW Charles, BC Dilworth, RD Bushong, EJ Day |
Poultry science | 1966 |
Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques
G Woolfe, L Decsi, H Uehleke, S Archer, LS Harris, MW Whitehouse, JA Montgomery, E Jucker |
1965 | |
PHENINDIONE SENSITIVITY
A Hollman, HO Wong |
British medical journal | 1964 |
Hereditary Transmission of Exceptional Resistance to Coumarin Anticoagulant Drugs: The First Reported Kindred
RA O'Reilly, PM Aggeler, MS Hoag, LS Leong, ML Kropatkin |
New England Journal of Medicine | 1964 |